Jacob Gottlieb and Stuart Weisbrod will be sharing an office once again. These two major figures in healthcare previously worked together at Merlin BioMid Group will once again collaborate in healthcare investing.
Weisbrod is he co-founder of the Merlin company which is an investment management group. They invest in biotechnology, medical devices, and other areas of healthcare. He has an MBA in Finance from Columbia and a PhD in Biochemistry from Princeton. He has worked with Jacob Gottlieb before and these two professionals were some of the first to invest in biotechnology. They made a profit of one hundred percent and got larger returns for many of their clients. They helped their clients invest in pensions and family offices. While the company was very successful they shut down in 2007.
Since Merlin has shut down, Weisbrod developed a new management firm called Iguana Healthcare Partners. This is another firm that invests in the healthcare field. The firm invests in biotechnology and other forms of technology in the healthcare field.
Jacob Gottlieb has his own investment company for some time as well. He opened Visium Asset Management and this company dealt with billions of dollars in just a couple of years. The company survived the downfall of 2008 and still employees over 200 people to handle all of the business accounts.
Even though Visium was very successful the company shut down in 2016 due to executives being accused of some questionable practices. Jason Thorell was the whistleblower and he spend 2 years gathering evidence against the heads of the company.
Visium has not commented on the accusations. Gottlieb has not been charged with any crimes and worked hard to return the funds to the investors at the company. He is still well respected in the investment world. He is now working in the same office as Weisbrod and they are looking to make some changes to the healthcare company.